Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces boulardii plus vancomycin for Clostridioides difficile infection
TCTR20241202006Phase 3Completed
- Sponsor
- Chiang Mai University
- Start
- Nov 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of saccharomyces boulardii in Clostridioides difficile colitis (CDI), sponsored by Chiang Mai University. Started Nov 2021; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on TCTR20241202006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241202006.